Please call your physician’s office before coming in for your appointment if you have symptoms of a cough, fever, or difficulty breathing; traveled to Europe or China or other areas impacted by the coronavirus (COVID-19) within the past 14 days; been in close contact with someone who has traveled outside the U.S. to one of the impacted countries; or may have been exposed to the coronavirus.  For our patients protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. Our new office hours are: Monday through Friday 8:30 a.m. to 4:00 p.m, if you have an appointment scheduled for after hours, our office will be contacting you directly to reschedule. FOR THE LATEST UP TO DATE INFORMATION, ALERTS AND CANCELLATIONS PLEASE CLICK HERE

Physician Publications

Physician Publications

October 4, 2017

A pilot study utilizing molecular profiling to find potential targets and select individualized treatments for patients with metastatic breast cancer.

Read More
July 11, 2017

Patient Case Lessons: Endocrine Management of Advanced Breast Cancer

Read More
May 11, 2017

Molecular Testing to Optimize and Personalize Decision Making in the Management of Colorectal Cancer

Read More
April 3, 2017

American Society of Clinical Oncology Position Statement: Strategies for Reducing Cancer Health Disp

Read More
February 10, 2017

Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2- breast cancer that had progressed during or after prior endocrine therapy.

Read More
February 6, 2017

Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised phase III trial with prospective biomarker evaluation.

Read More